Format

Send to

Choose Destination
See comment in PubMed Commons below
Ugeskr Laeger. 2011 Jun 27;173(26):1863-9.

[Weight reducing and glucose reducing effects of liraglutide treatment for patients with type 2 diabetes].

[Article in Danish]

Author information

1
Steno Diabetes Center, Niels Steensensvej 2, 2820 Gentofte, Denmark. epenninga@hotmail.com

Abstract

Treatment with glucagon-like peptide-1 analogues including liraglutide is a new treatment option for patients with type 2 diabetes. Treatment with liraglutide decreases HbA1c by 1-2%, and additionally liraglutide has a reducing effect on weight, lipids and blood pressure. Most adverse events are related to the gastrointestinal system and most often they disappear within a few weeks. The risk of major hypoglycaemic episodes is minimal. Long term data on treatment and adverse events with liraglutide are still lacking.

PMID:
21712007
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center